Shows
The Syneos Health PodcastEpisode 022: Spending for Launch SuccessWhen it comes to investing in the launch of your biopharma product, how much is too much? Is there such a thing as too little? Director Sachin Purwar and his colleagues from the Commercial Strategy & Planning practice of Syneos Health Consulting set out to answer these questions - and found the "sweet spot" for launch spending that could mean the difference between success and failure.
The team's review of 19 emerging biopharma company launches was recently published in IN VIVO. In this episode, Sachin discusses with host Jeff Stewart special considerations, pitfalls to avoid, and the implications of s...
2018-09-1915 minThe Syneos Health PodcastEpisode 019: A Decade of Dealmakers' IntentionsThe last decade has seen both depressing lows and astounding highs in biopharmaceutical dealmaking activity. Different therapeutic areas have fallen in and out of favor along with the pace of innovation and there has been a sustained focus on the next "hot spot" with high commercial value and the potential to provide solid returns for stakeholders. But certain trends have been persistent. What has changed? What has remained the same?
Neel Patel, Managing Director and Sachin Purwar, Director at Syneos Health Consulting discuss the last ten years of dealmaking and take a look forward based on the...
2018-06-0816 minThe Syneos Health PodcastEpisode 005: The Room Where it Happens: Dealmakers' Intentions 2017At the BIO International Convention, arguably the largest and most important biopharma partnering event of the year with over 16,000 participants, it's all about getting the deal done. While the industry will very likely not see the extremely high level of licensing and M&A activity it did back in 2015, the year is shaping up to reach a respectable level closer to historical norms, according to Sachin Purwar, Senior Engagement Manager in the Commercial Strategy & Planning practice of inVentiv Health Consulting and one of the authors of the 2017 Dealmakers' Intentions Study -- the ninth in a series and a forward-looking...
2017-06-2018 min